R
RDY
Dr. Reddy's Laboratories Limited American Depositary Shares
$12.75
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Dr. Reddy's Laboratories Limited American Depositary Shares in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
$0.09
Yield
0.71%
EPS
$38.67
P/E
32.0
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $9.35
Oct 23
Posts
No posts about RDY yet.
About Dr. Reddy's Laboratories Limited American Depositary Shares
Dr. Reddy's Laboratories is an Indian pharmaceutical company that manufactures and sells generic drugs, active pharmaceutical ingredients (the raw chemical building blocks used in medicines), and biosimilars (close copies of complex biotech drugs) across the US, Europe, India, and other emerging markets. It makes money by producing lower-cost versions of medicines after the original brand's patent expires and selling them to pharmacies, hospitals, and distributors worldwide. US investors buy into the company through an American Depositary Share, a certificate that represents ownership in the India-listed stock.